Gram-Negative Bacterial Infection Therapeutics Market - Global Outlook and Forecast 2023-2028

Report ID: 1377054 | Published Date: Jan 2025 | No. of Page: 65 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Gram-Negative Bacterial Infection Therapeutics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Gram-Negative Bacterial Infection Therapeutics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Gram-Negative Bacterial Infection Therapeutics Overall Market Size
    2.1 Global Gram-Negative Bacterial Infection Therapeutics Market Size: 2021 VS 2028
    2.2 Global Gram-Negative Bacterial Infection Therapeutics Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Gram-Negative Bacterial Infection Therapeutics Players in Global Market
    3.2 Top Global Gram-Negative Bacterial Infection Therapeutics Companies Ranked by Revenue
    3.3 Global Gram-Negative Bacterial Infection Therapeutics Revenue by Companies
    3.4 Top 3 and Top 5 Gram-Negative Bacterial Infection Therapeutics Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Gram-Negative Bacterial Infection Therapeutics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Gram-Negative Bacterial Infection Therapeutics Players in Global Market
        3.6.1 List of Global Tier 1 Gram-Negative Bacterial Infection Therapeutics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Gram-Negative Bacterial Infection Therapeutics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Gram-Negative Bacterial Infection Therapeutics Market Size Markets, 2021 & 2028
        4.1.2 Enteral Treatment
        4.1.3 Parenteral Treatment
        4.1.4 Topical Treatment
    4.2 By Type - Global Gram-Negative Bacterial Infection Therapeutics Revenue & Forecasts
        4.2.1 By Type - Global Gram-Negative Bacterial Infection Therapeutics Revenue, 2017-2022
        4.2.2 By Type - Global Gram-Negative Bacterial Infection Therapeutics Revenue, 2023-2028
        4.2.3 By Type - Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Gram-Negative Bacterial Infection Therapeutics Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Others
    5.2 By Application - Global Gram-Negative Bacterial Infection Therapeutics Revenue & Forecasts
        5.2.1 By Application - Global Gram-Negative Bacterial Infection Therapeutics Revenue, 2017-2022
        5.2.2 By Application - Global Gram-Negative Bacterial Infection Therapeutics Revenue, 2023-2028
        5.2.3 By Application - Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Gram-Negative Bacterial Infection Therapeutics Market Size, 2021 & 2028
    6.2 By Region - Global Gram-Negative Bacterial Infection Therapeutics Revenue & Forecasts
        6.2.1 By Region - Global Gram-Negative Bacterial Infection Therapeutics Revenue, 2017-2022
        6.2.2 By Region - Global Gram-Negative Bacterial Infection Therapeutics Revenue, 2023-2028
        6.2.3 By Region - Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Gram-Negative Bacterial Infection Therapeutics Revenue, 2017-2028
        6.3.2 US Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
        6.3.3 Canada Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
        6.3.4 Mexico Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Gram-Negative Bacterial Infection Therapeutics Revenue, 2017-2028
        6.4.2 Germany Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
        6.4.3 France Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
        6.4.4 U.K. Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
        6.4.5 Italy Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
        6.4.6 Russia Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
        6.4.7 Nordic Countries Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
        6.4.8 Benelux Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Gram-Negative Bacterial Infection Therapeutics Revenue, 2017-2028
        6.5.2 China Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
        6.5.3 Japan Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
        6.5.4 South Korea Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
        6.5.5 Southeast Asia Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
        6.5.6 India Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Gram-Negative Bacterial Infection Therapeutics Revenue, 2017-2028
        6.6.2 Brazil Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
        6.6.3 Argentina Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Revenue, 2017-2028
        6.7.2 Turkey Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
        6.7.3 Israel Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
        6.7.4 Saudi Arabia Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
        6.7.5 UAE Gram-Negative Bacterial Infection Therapeutics Market Size, 2017-2028
7 Players Profiles
    7.1 Baxter
        7.1.1 Baxter Corporate Summary
        7.1.2 Baxter Business Overview
        7.1.3 Baxter Gram-Negative Bacterial Infection Therapeutics Major Product Offerings
        7.1.4 Baxter Gram-Negative Bacterial Infection Therapeutics Revenue in Global Market (2017-2022)
        7.1.5 Baxter Key News
    7.2 Sanofi
        7.2.1 Sanofi Corporate Summary
        7.2.2 Sanofi Business Overview
        7.2.3 Sanofi Gram-Negative Bacterial Infection Therapeutics Major Product Offerings
        7.2.4 Sanofi Gram-Negative Bacterial Infection Therapeutics Revenue in Global Market (2017-2022)
        7.2.5 Sanofi Key News
    7.3 GlaxoSmithKline
        7.3.1 GlaxoSmithKline Corporate Summary
        7.3.2 GlaxoSmithKline Business Overview
        7.3.3 GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Major Product Offerings
        7.3.4 GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Revenue in Global Market (2017-2022)
        7.3.5 GlaxoSmithKline Key News
    7.4 Novartis
        7.4.1 Novartis Corporate Summary
        7.4.2 Novartis Business Overview
        7.4.3 Novartis Gram-Negative Bacterial Infection Therapeutics Major Product Offerings
        7.4.4 Novartis Gram-Negative Bacterial Infection Therapeutics Revenue in Global Market (2017-2022)
        7.4.5 Novartis Key News
    7.5 Pfizer
        7.5.1 Pfizer Corporate Summary
        7.5.2 Pfizer Business Overview
        7.5.3 Pfizer Gram-Negative Bacterial Infection Therapeutics Major Product Offerings
        7.5.4 Pfizer Gram-Negative Bacterial Infection Therapeutics Revenue in Global Market (2017-2022)
        7.5.5 Pfizer Key News
    7.6 Takeda
        7.6.1 Takeda Corporate Summary
        7.6.2 Takeda Business Overview
        7.6.3 Takeda Gram-Negative Bacterial Infection Therapeutics Major Product Offerings
        7.6.4 Takeda Gram-Negative Bacterial Infection Therapeutics Revenue in Global Market (2017-2022)
        7.6.5 Takeda Key News
    7.7 Nektar Therapeutics
        7.7.1 Nektar Therapeutics Corporate Summary
        7.7.2 Nektar Therapeutics Business Overview
        7.7.3 Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Major Product Offerings
        7.7.4 Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Revenue in Global Market (2017-2022)
        7.7.5 Nektar Therapeutics Key News
    7.8 Sumitomo
        7.8.1 Sumitomo Corporate Summary
        7.8.2 Sumitomo Business Overview
        7.8.3 Sumitomo Gram-Negative Bacterial Infection Therapeutics Major Product Offerings
        7.8.4 Sumitomo Gram-Negative Bacterial Infection Therapeutics Revenue in Global Market (2017-2022)
        7.8.5 Sumitomo Key News
    7.9 Targeted Genetics
        7.9.1 Targeted Genetics Corporate Summary
        7.9.2 Targeted Genetics Business Overview
        7.9.3 Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Major Product Offerings
        7.9.4 Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Revenue in Global Market (2017-2022)
        7.9.5 Targeted Genetics Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Gram-Negative Bacterial Infection Therapeutics Market Opportunities & Trends in Global Market
    Table 2. Gram-Negative Bacterial Infection Therapeutics Market Drivers in Global Market
    Table 3. Gram-Negative Bacterial Infection Therapeutics Market Restraints in Global Market
    Table 4. Key Players of Gram-Negative Bacterial Infection Therapeutics in Global Market
    Table 5. Top Gram-Negative Bacterial Infection Therapeutics Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Gram-Negative Bacterial Infection Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Gram-Negative Bacterial Infection Therapeutics Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Gram-Negative Bacterial Infection Therapeutics Product Type
    Table 9. List of Global Tier 1 Gram-Negative Bacterial Infection Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Gram-Negative Bacterial Infection Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Gram-Negative Bacterial Infection Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Gram-Negative Bacterial Infection Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Gram-Negative Bacterial Infection Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Gram-Negative Bacterial Infection Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 30. Baxter Corporate Summary
    Table 31. Baxter Gram-Negative Bacterial Infection Therapeutics Product Offerings
    Table 32. Baxter Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 33. Sanofi Corporate Summary
    Table 34. Sanofi Gram-Negative Bacterial Infection Therapeutics Product Offerings
    Table 35. Sanofi Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 36. GlaxoSmithKline Corporate Summary
    Table 37. GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Product Offerings
    Table 38. GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 39. Novartis Corporate Summary
    Table 40. Novartis Gram-Negative Bacterial Infection Therapeutics Product Offerings
    Table 41. Novartis Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 42. Pfizer Corporate Summary
    Table 43. Pfizer Gram-Negative Bacterial Infection Therapeutics Product Offerings
    Table 44. Pfizer Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 45. Takeda Corporate Summary
    Table 46. Takeda Gram-Negative Bacterial Infection Therapeutics Product Offerings
    Table 47. Takeda Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 48. Nektar Therapeutics Corporate Summary
    Table 49. Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Product Offerings
    Table 50. Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 51. Sumitomo Corporate Summary
    Table 52. Sumitomo Gram-Negative Bacterial Infection Therapeutics Product Offerings
    Table 53. Sumitomo Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 54. Targeted Genetics Corporate Summary
    Table 55. Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Product Offerings
    Table 56. Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Gram-Negative Bacterial Infection Therapeutics Segment by Type in 2021
    Figure 2. Gram-Negative Bacterial Infection Therapeutics Segment by Application in 2021
    Figure 3. Global Gram-Negative Bacterial Infection Therapeutics Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Gram-Negative Bacterial Infection Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Gram-Negative Bacterial Infection Therapeutics Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Gram-Negative Bacterial Infection Therapeutics Revenue in 2021
    Figure 8. By Type - Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2017-2028
    Figure 12. US Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2017-2028
    Figure 16. Germany Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 17. France Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2017-2028
    Figure 24. China Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 28. India Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2017-2028
    Figure 30. Brazil Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2017-2028
    Figure 33. Turkey Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 37. Baxter Gram-Negative Bacterial Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Sanofi Gram-Negative Bacterial Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Novartis Gram-Negative Bacterial Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Pfizer Gram-Negative Bacterial Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Takeda Gram-Negative Bacterial Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Sumitomo Gram-Negative Bacterial Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
65
Frequently Asked Questions
Gram-Negative Bacterial Infection Therapeutics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gram-Negative Bacterial Infection Therapeutics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gram-Negative Bacterial Infection Therapeutics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports